Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jessica Cruz-Mora has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Marisín Pecchio

    Center for Academic Affairs and Collaboration, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama

    3 shared publications
  • Johant Lakey-Beitia

    División de Bioprospección y Descubrimiento de Fármacos, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama

    2 shared publications
  • Kosagi Sharaf Jagannatha Rao

    Department of Biotechnology, Koneru Lakshmaiah Education Foundation (Deemed to be University), Vaddeswaram 522302, India

    2 shared publications
  • Lakshmi Sowmya Emani

    Department of Biotechnology, KLEF Deemed to be University, Vijayawada, India

    2 shared publications
  • Adrian L. Orjuela

    Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Panama City 0843-01103, Panama

    1 shared publication
  • Arelys L. Fuentes

    Center for Biodiversity and Drug Discovery, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama

    1 shared publication

Latest Publications

  • Open Access

    Insights into the Structural Patterns in Human Glioblastoma Cell Line SF268 Activity and ADMET Prediction of Curcumin Derivatives

    by Lorena Coronado, Johant Lakey-Beitia, Marisin Pecchio, Michelle G. Ng, Ricardo Correa, Gerardo Samudio-Ríos, Jessica Cruz-Mora, Arelys L. Fuentes, K. S. Jagannatha Rao, Carmenza Spadafora

    Background/Objectives: Curcumin is a promising therapy for glioblastoma but is limited by poor water solubility, rapid metabolism, and low blood–brain barrier penetration. This study aimed to evaluate curcumin and six curcumin derivatives with improved activity against a glioblastoma cell line and favorable absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties. Methods: Twenty-one curcumin derivatives were assessed and subjected to in vitro MTT cytotoxicity assays in SF268 glioblastoma and Vero cells. On the basis of the cytotoxicity results, six derivatives with the most favorable characteristics were selected for additional mechanistic studies, which included microtubule depolymerization, mitochondrial membrane potential (ΔΨm), and BAX activation assays. ADMET properties were determined in silico. Results: Compounds 2–4, 6, and 11 demonstrated better activity (IC50: 0.59–3.97 µg/mL and SI: 3–20) than curcumin (IC50: 6.3 µg/mL; SI: 2.5). Lead derivatives destabilized microtubules, induced ΔΨm collapse, and activated BAX. In silico ADMET prediction analysis revealed that compounds 4 and 6 were the most promising for oral administration from a biopharmaceutical and pharmacokinetic point of view. Conclusions: Strategic modifications were made to one or both hydroxyl groups of the aromatic rings of curcumin to increase its physicochemical stability and activity against glioblastoma cell line SF268. Compound 4, bearing fully protected aromatic domains, was identified as a prime candidate for in vivo validation and formulation development.

    • 9 June 2025
      • Vol. 9
    Open Access

    Studies on curcumin-glucoside in the prevention of alpha-synuclein aggregation

    by Lakshmi Sowmya Emani, Jayanth K Rao, Jagadeesha Kumar Dasappa, Marisín Pecchio, Johant Lakey-Beitia, Hansapani Rodriguez, Jessica Cruz-Mora, Priya Narayan, Nikhilesh Anand, Govindaraju Mullur, et al.

    α-synuclein (α-syn) deposition in the mid-brain region is one of the hallmark pathologies of Parkinson's disease (PD). The key steps involve the transformation of α-synuclein into a toxic oligomer and insoluble fibrillar aggregates. To understand the role of curcumin-glucoside in the prevention of α-syn aggregation, a mechanistic approach. In the present study, we synthesized a novel molecule, curcumin-glucoside (Curc-gluc), to improve the water solubility and partition coefficient, making the molecule with high bioavailability. The present study is focused on understanding the α-syn aggregation kinetics in the presence and absence of Curc-gluc, curcumin (Cur), copper (Cu), and iron (Fe) through Thioflavin T analysis, circular dichroism (CD), mathematical approach by self-association kinetics, and molecular docking models. The results indicated that Curc-gluc potentially prevented synuclein aggregation compared to Curc alone and inhibited Cu and Fe-induced synuclein aggregation. CD studies indicated that Curc-gluc favored α-helix formation. The docking studies indicated that Curc-gluc derivatives interacted with various chains of α-syn fibrils, namely G-chain, A-chain, I-Chain, and E-chain and the Pi-Pi interaction indicate that, Curc-gluc shows the most favorable binding affinity with the α-syn fibrils with 60.7222 kcal/mol of -CDOCKER_ ENERGY and 89.6516 kcal/mol of -CDOCKER INTERACTION_ ENERGY. The Absorption, Distribution, Metabolism, Excretion (ADME) analysis indicated that Curc-mono and di-gluc have the highest solubility, bioavailability, and tissue distribution compared to Curc alone. The studies indicated that Curc-gluc prevented α-syn aggregation by favoring α-helix, binding to α-syn, and preventing aggregation, and had high bioavailability.


  • The role of carotenoids from red mamey fruit ( Pouteria sapota ) against amyloid-β monomers in Alzheimer's disease: Computational analysis and ADMET prediction

    by Adrián L Orjuela, Marisín Pecchio, Jessica Cruz-Mora, Lakshmi Sowmya Emani, Maria B Carreira, Oleg V Larionov, Muralidhar L Hegde, K S Jagannatha Rao, Jorge Alí-Torres, Johant Lakey-Beitia

    Background: Carotenoids, potent antioxidants in fruits and vegetables, have recently garnered attention for their potential therapeutic effects against neurodegenerative diseases. This study focuses on the interaction and anti-aggregation properties of conventional and unconventional carotenoids found in red mamey fruit, a nutraceutical fruit that is a rich source of these compounds. Objective: To assess computational the interaction between of amyloid-β (Aβ) peptide with a set of carotenoids and three carotenoids previously explored in experimental assays as well as to assess ADMET prediction of carotenoids selected by computational analysis results. Methods: We analyzed the interaction between these carotenoids and Aβ peptides using molecular docking, a key factor in Alzheimer's disease (AD) pathology. Selected carotenoids were compared with the reference compounds cryptocapsin ( 1 ), zeaxanthin ( 2 ), lutein ( 3 ), and cryptocapsin-5,6-epoxide ( 24 ), which previously demonstrated significant anti-aggregation activity against Aβ. Using SwissADME and ADMET Predictor ® software to determine the pharmaceutical analysis prediction. Results: Computational analysis identified (5R,8R)-sapotexanthin-5,8-epoxide ( 19 ) and (5S,8S)-cryptocapsin-5,8-epoxide ( 26 ) as the most promising candidates due to their strong binding affinity and potential anti-aggregation properties against Aβ. The pharmaceutical analysis identified compounds (5S,8S)-cryptocapsin-5,8-epoxide ( 26 ) and (5R,8R)-cryptocapsin-5,8-epoxide ( 28 ) as the most promising compounds. Our findings suggest that specific modifications in the carotenoid structure, particularly modifications in the type of epoxidation and stereochemistry, can significantly influence the biological activity of carotenoids and biopharmaceutical performance. Conclusions: These results provide valuable insights for future in vitro studies of most potential carotenoids (19 and 26) and the development of potential therapeutic agents for AD.